healthcarenewswire’s blog

We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

How is Rising Incidence of COVID-19 Driving Malaria Treatment Industry?

The surging number of COVID-19 cases across the globe is a primary concern at the present time for the healthcare industry and really the whole world. Not only has the disease spread around the world quickly, no treatment has yet been developed for curing it. Because of this, the affected people are being treated by using medication for other diseases, such as malaria. For instance, the U.S. Food and Drug Administration issued an emergency use authorization on March 30, 2020, thereby allowing the utilization of chloroquine and hydroxychloroquine products for treating adult and adolescent patients suffering from COVID-19.

f:id:vijaymishrapsmarket1:20200818231106p:plain

After the authorization and positive effect of hydroxychloroquine against COVID-19, the Indian Government exported large quantity of the drug to the U.S. In addition to this, three Gujarat-based companies have also started the production of the drug for providing supplies to the U.S. these factors are predicted to result in the rapid growth of the malaria treatment market in the coming years. Other than COVID-19, the prevalence of malaria itself is increasing all over the world. As per the World Intellectual Property Organization, malaria is an infectious life-threatening disease and affected more than 200 million people in 2018, worldwide.

As per the November 2019 article by the American Association for Clinical Chemistry, malaria infections and malaria morality majorly occur in the African region. Besides this, large number of cases have also been reported in parts of Caribbean, Central and South America, Asia, including Southeast Asia and South Asia, South Pacific, Eastern Europe, and Middle East. The World Health Organization reported about 198 million cases and 584,000 deaths in 2013 due to malaria across the globe. This is resulting in the growth of the malaria treatment market.

In conclusion, the growing prevalence of COVID-19 and malaria is driving the demand for malaria treatment around the world. 

Read More: https://www.psmarketresearch.com/market-analysis/malaria-treatment-market